Dr. Reddy’s Lab launches Vigabatrin Powder for Oral Solution

20 Aug 2019

Dr. Reddy’s Laboratories has launched Vigabatrin Powder for Oral Solution, USP in 500 mg per packet, a therapeutic equivalent generic version of Sabril (vigabatrin) Powder for Oral Solution, USP, approved by the U.S. Food and Drug Administration (USFDA). Dr. Reddy's Vigabatrin Powder for Oral Solution, USP is available in 500 mg per packet in count size of 50 per carton.

The Sabril brand and generic had U.S. sales of approximately $274 million MAT for the most recent twelve months ending in June 2019 according to IMS Health.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Related Dr. Reddys Laboratories Ltd. Links:

Dr. Reddys Lab Share Price

4842.45 61.85 (1.29%) Apr 15, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 632.95
Dr. Reddys Lab 4842.45
Lupin 1046.00
Piramal Enterprises 1715.00
Cadila Healthcare 504.00
View more..
Sensex vs Dr. Reddys Lab
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback